Remove Doctors Remove Research Remove Vaccine
article thumbnail

Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine

The Pharma Data

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s coronavirus vaccine. Many countries have criticised Russia pursuit for a COVID-19 cure, which has skipped Phase 3 trials before giving the vaccine regulatory approval. Safety always comes first.

article thumbnail

US experts stress over safety of AZ’s COVID-19 vaccine

pharmaphorum

US medical experts are reportedly concerned that a neurological side effect picked up in AstraZeneca’s closely-watched COVID-19 vaccine trial could compromise the whole project, as the FDA weighs whether to give the go ahead for US studies to resume. The post US experts stress over safety of AZ’s COVID-19 vaccine appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

NY Times

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

article thumbnail

Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response

pharmaphorum

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.

article thumbnail

Moderna’s COVID-19 Vaccine Candidate Shows Almost 95 Percent Effectiveness in Interim Analysis

XTalks

Moderna announced today that its highly anticipated COVID-19 vaccine candidate appears to be 94.5 The news comes shortly after Pfizer and BioNTech’s mega announcement last week of their COVID-19 vaccine having shown 90 percent efficacy in an ongoing large-scale Phase III trial. The vaccine is given in two doses.

article thumbnail

Doctor communication key to pandemic vaccine adoption

Scienmag

. – People who talk with their doctors are more likely to get vaccinated during a pandemic, according to a study of evidence collected during the “swine flu,” the last pandemic to hit the U.S. before COVID-19.

Doctors 45
article thumbnail

AZ COVID-19 vaccine cleared in UK, dosing to start next week

pharmaphorum

The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the fight against the pandemic, with first doses due to be administered on Monday. The #coronavirus vaccine is our way out of the pandemic – now we need to hold our nerve while we get through this together.